バイオサージェリーの世界市場予測（～2021）：フィブリンシーラント、コラーゲンシーラント、止血鉗子、癒着防止バリア、生物学的メッシュ、軟組織付着、ステープラー、骨移植片...市場調査レポートについてご紹介

1 Introduction (Page No. – 25)
1.1 Objectives of the Study
1.2 Biosurgery Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 28)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Biosurgery Market Size Estimation
2.3 Biosurgery Market Breakdown and Data Triangulation
2.4 Biosurgery Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 35)

4 Premium Insights (Page No. – 39)
4.1 Biosurgery Products: Market Overview
4.2 Asia-Pacific: Natural/Biological Sealants Market, By Type (2015)
4.3 Geographic Snapshot of the Biosurgery Products Market
4.4 Regional Mix of the Biosurgery Products Market
4.5 Biosurgery Products Market: Developed vs Developing Countries

5 Market Overview (Page No. – 43)
5.1 Introduction
5.2 Biosurgery Market Dynamics
5.3 Biosurgery Market Drivers
5.3.1 Rising Number of Surgeries
5.3.2 Approval of A Number of New and Advanced Biosurgery Products By Regulatory Authorities
5.3.3 Increasing Incidence of Sports-Related Injuries and Spinal Ailments
5.3.4 Increasing Focus on Effective Blood Loss Management in Patients During Surgeries
5.4 Market Restraint
5.4.1 Unfavorable Reimbursement Scenario for Biosurgery Products
5.5 Market Opportunity
5.5.1 Improving Healthcare Systems in Emerging Markets
5.6 Market Challenges
5.6.1 High Price of Biosurgery Products & Rising Cost of Surgical Procedures
5.6.2 Requirement of Skilled Personnel for Effective Use of Biosurgery Products

6 Industry Insights (Page No. – 50)
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Preference for Biological Meshes in Surgical Procedures
6.2.2 Introduction of New Technologies in the Biosurgery Products Market
6.2.3 Growth in the Number of Acquisitions in the Biosurgery Products Market
6.3 Regulatory Analysis
6.3.1 North America
6.3.1.1 U.S.
6.3.1.2 Canada
6.3.2 Europe
6.3.3 APAC
6.3.3.1 Japan
6.3.3.2 China
6.3.3.3 India
6.4 Vendor Benchmarking

7 Biosurgery Products Market, By Type (Page No. – 59)
7.1 Introduction
7.2 Sealants
7.2.1 Natural/Biological Sealants
7.2.1.1 Natural/Biological Sealants, By Type
7.2.1.1.1 Fibrin Sealants
7.2.1.1.2 Gelatin-Based Sealants
7.2.1.1.3 Collagen-Based Sealants
7.2.1.1.4 Other Natural Sealants
7.2.1.2 Natural/Biological Sealants, By Origin
7.2.1.2.1 Human Blood-Based Sealants
7.2.1.2.2 Animal-Based Sealants
7.2.2 Synthetic and Semi-Synthetic Sealants
7.2.2.1 Cyanoacrylates
7.2.2.2 Polymeric Hydrogels
7.2.2.3 Urethane-Based Sealants
7.2.2.4 Other Synthetic and Semi-Synthetic Sealants
7.3 Hemostatic Agents
7.4 Adhesion Barriers
7.4.1 Synthetic Adhesion Barriers
7.4.1.1 Regenerated Cellulose
7.4.1.2 Hyaluronic Acid (HA)
7.4.1.3 Polyethylene Glycol (PEG)
7.4.1.4 Others
7.4.2 Natural Adhesion Barriers
7.4.2.1 Fibrin-Based Adhesion Barriers
7.4.2.2 Collagen & Protein
7.5 Soft Tissue Attachments (Patch/Mesh)
7.5.1 Synthetic Meshes
7.5.2 Biological Meshes
7.5.2.1 Allografts
7.5.2.2 Xenografts
7.6 Bone Graft Substitutes
7.6.1 Bone Allografts
7.6.2 Demineralized Bone Matrix (DBM)
7.6.3 Bone Morphogenetic Proteins (BMP)
7.6.4 Synthetic Bone Grafts
7.7 Staple Line Reinforcement Agents

8 Biosurgery Products Market, By Application (Page No. – 105)
8.1 Introduction
8.2 Orthopedic Surgeries
8.3 General Surgeries
8.4 Neurological Surgeries
8.5 Cardiovascular Surgeries
8.6 Reconstructive Surgeries
8.7 Gynecological Surgeries
8.8 Urological Surgeries
8.9 Thoracic Surgeries

9 Biosurgery Products Market, By Region (Page No. – 119)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (RoE)
9.4 Asia-Pacific (APAC)
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific (RoAPAC)
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa

10 Competitive Landscape (Page No. – 222)
10.1 Overview
10.2 Market Share Analysis
10.2.1 Sealants and Hemostatic Agents
10.2.2 Bone Graft Substitutes
10.2.3 Adhesion Barriers
10.3 Competitive Situations and Trends
10.3.1 Agreements and Collaborations
10.3.2 Product Launches
10.3.3 Acquisitions
10.3.4 Expansions
10.3.5 Other Developments

11 Company Profiles (Page No. – 230)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Baxter International Inc.
11.3 C.R. Bard, Inc.
11.4 Covidien PLC (A Subsidiary of Medtronic, Inc.)
11.5 Johnson & Johnson Services, Inc.
11.6 Sanofi Group
11.7 Atrium Medical Corporation (A Part of Getinge Group)
11.8 B. Braun Melsungen AG
11.9 Cryolife, Inc.
11.10 Stryker Corporation
11.11 Hemostasis, LLC

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 253)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details